Evaluation of effectiveness and safety of Capecitabine monotherapy in patients with Anthracycline-pretreated Metastatic Breast Cancer:A multicenter phase2 study
Phase 2
- Conditions
- Metastatic Breast Cancer
- Registration Number
- JPRN-C000000260
- Lead Sponsor
- KBCSG (Kinki Breast Cancer Study Group)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1) have capecitabine before 2) Hypersensitivity to drugs 3) severe complication 4) active double cancer 5) in pregnancy or lactation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method